Journal Articles
Our work in Journal Articles
-
Know Your Epidemic, Know Your Response: Early Perceptions of COVID-19 and Self-Reported Social Distancing in the United States
we study individual’s perceptions on COVID-19 and social distancing during the week of March 10–16, 2020, a week when COVID-19 was officially declared to be a pandemic by WHO and when new infections in the US were more than doubling every three days.
Categorized in -
Impacts on the U.S. Macroeconomy of Mandatory Business Closures in Response to the COVID-19 Pandemic
A mandatory business closure over three months results in a 20.3% decline of U.S. GDP on an annual basis, or $4.3 trillion, and an employment decline of 22.4%, representing 35.3 million workers.
Categorized in -
Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review
This analysis highlights that most cost-utility analyses that cite high cost-effectiveness thresholds also result in greater incremental cost-effectiveness ratios for the novel interventions that they investigate.
Categorized in -
Blood‐Based Biomarkers for Alzheimer’s Pathology and the Diagnostic Process for a Disease‐Modifying Treatment: Projecting the Impact on the Cost and Wait Times
Blood‐based biomarker tests are a promising tool to improve triaging Alzheimer’s disease at the primary care level.
Categorized in -
The “Advancing American Kidney Health” Executive Order: Challenges and Opportunities for the Large Dialysis Organizations
This perspective in the American Journal of Kidney Diseases examines how the “Advancing American Kidney Health” Executive Order (AAKH) might reshape the US dialysis market.
Categorized in -
Short-Term Impact of Income on Cognitive Function: Evidence From a Sample of Mexican Older Adults
In low- and middle-income countries, supplemental income for the elderly may be an effective strategy to improve cognitive function by increasing food security and health care utilization.
Categorized in -
Uptake of Infliximab Biosimilars Among the Medicare Population
Two years after launch, biosimilars for rheumatoid arthritis and other lifelong conditions captured little market share.
Categorized in -
Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model
There is a significant burden of disease among individuals with CHD; the disease affects quality of life, disability, life expectancy, medical spending, chronic disease, as well as employment and education outcomes.
Categorized in -
The State of the Science in Opioid Policy Research
A review of 145 opioid policy evaluation studies found that greater adoption of more rigorous study designs and statistical methods is warranted.
-
Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data
This study provides the first comparison of trends in dementia prevalence in the U.S. population using 3 different dementia ascertainments/data sources. They found there are still substantial differences across measures in dementia prevalence among Blacks and Hispanics.